Therapeutic potential of sildenafil in patients with heart failure and reactive pulmonary hypertension

International Journal of Cardiology

Volumn 154, Issue 2, 2012, Pages 205-206

  Dumitrescu, Daniel ^a   Seck, Cathérine ^a   Möhle, Luise ^a   Erdmann, Erland ^a   Rosenkranz, Stephan ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Heart failure; Pulmonary hypertension; Sildenafil

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; PLACEBO; PROSTACYCLIN; SILDENAFIL; VASODILATOR AGENT;

ADD ON THERAPY; ADULT; AGED; BIVENTRICULAR HEART FAILURE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG SAFETY; EXERCISE TOLERANCE; HEART FAILURE; HEART FUNCTION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE PRESSURE; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE CONTRACTILITY; HEART RIGHT VENTRICLE FUNCTION; HEART WORK; HUMAN; LETTER; PHYSICAL CAPACITY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PULMONARY HYPERTENSION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

EID: 84855822103     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2011.10.064     Document Type: Article

References (8)

1. N. Galiè, M.M. Hoeper, and M. Humbert Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT) Eur Heart J 30 2009 2493 2537
2. S. Ghio, A. Gavazzi, and C. Campana Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure J Am Coll Cardiol 37 2001 183 188 (Pubitemid 32051736)
3. M. Guazzi, M. Samaja, R. Arena, M. Vicenzi, and M.D. Guazzi Long-term use of sildenafil in the therapeutic management of heart failure J Am Coll Cardiol 50 2007 2136 2144 (Pubitemid 350117342)
4. G.D. Lewis, J. Lachmann, and J. Camuso Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure Circulation 115 2007 59 66 (Pubitemid 46058612)
5. R.M. Califf, K.F. Adams, and W.J. McKenna A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST) Am Heart J 134 1997 44 54 (Pubitemid 27329022)
6. M.R. Shah, S.S. Stinnett, and S.E. McNulty Hemodynamics as surrogate endpoints for survival in advanced heart failure: An analysis from FIRST Am Heart J 141 2001 909 914
7. J. Nagendran, S.L. Archer, and D. Soliman Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility Circulation 116 2007 238 248 (Pubitemid 47196559)
8. G.D. Lewis, and M.J. Semigran The emerging role for type 5 phosphodiesterase inhibition in heart failure Curr Heart Fail Rep 3 2006 123 128 (Pubitemid 44898467)